{"schema_version":"1","generated_at":"2026-11-04T17:51:32.567Z","data_as_of":"2026-11-04","url":"https://www.findmykol.com/kol/janellen-smith","json_url":"https://www.findmykol.com/kol/janellen-smith/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"janellen-smith","name":"Janellen Smith","credential":"MD","title":"Health Sciences Professor, Dermatology","specialty":"Dermatology","specialty_raw":"Dermatology","therapeutic_area":"Melanoma","therapeutic_areas":["Melanoma"],"institution":"University of California, Irvine","institution_url":"https://www.findmykol.com/institution/university-of-california-irvine","city":"Irvine","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1811948789","orcid":"0000-0001-7711-3626","openalex":"A5019486990"},"summary":"Janellen Smith is Health Sciences Professor, Dermatology at University of California, Irvine. OpenAlex indexes 69 publications with 517 citations (h-index 10); ClinicalTrials.gov lists 1 registered study with this person as an investigator.","overview":{"text":"Janellen Smith, MD, is Health Sciences Professor, Dermatology at University of California, Irvine (UC Irvine School of Medicine). The public record shows 69 publications with 517 citations (h-index 10), centered on Dermatology and Skin Diseases, Cutaneous Melanoma Detection and Management, Drug-Induced Adverse Reactions. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 2 companies.","bullets":["Most recent indexed publication: 2025 · JMIR dermatology","Top research focus: Dermatology and Skin Diseases","1 registered trials on ClinicalTrials.gov","Open Payments reporting from 2 companies"],"generated_at":"2026-11-04"},"focus":{"indications":[{"label":"Acne / Hidradenitis","therapeutic_area":"Dermatology","trials":1,"topics":0,"strength":4},{"label":"Acne Vulgaris","therapeutic_area":"Dermatology","trials":1,"topics":0,"strength":3},{"label":"Paronychia","therapeutic_area":"Dermatology","trials":1,"topics":0,"strength":3},{"label":"IBD (Crohn's / UC)","therapeutic_area":"Gastroenterology","trials":0,"topics":0,"strength":1},{"label":"Lymphoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Psoriasis / Psoriatic Arthritis","therapeutic_area":"Rheumatology/Immunology","trials":0,"topics":0,"strength":1},{"label":"Lung Cancer (NSCLC/SCLC)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Head & Neck Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Tuberculosis","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Multiple Myeloma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Colorectal Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Psoriasis (Derm)","therapeutic_area":"Dermatology","trials":0,"topics":0,"strength":1},{"label":"Melanoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Atopic Dermatitis / Eczema","therapeutic_area":"Dermatology","trials":0,"topics":0,"strength":1},{"label":"Sarcoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Pulmonary Hypertension","therapeutic_area":"Cardiology","trials":0,"topics":0,"strength":1}],"research_topics":["Dermatology and Skin Diseases","Cutaneous Melanoma Detection and Management","Drug-Induced Adverse Reactions","Chemotherapy-related skin toxicity","Cancer and Skin Lesions"],"drugs_studied":{"total":2,"shown":2,"withheld":0,"rows":[{"name":"Rybrevant","generic":"Amivantamab","trials":0,"payments":3,"publications":2,"mentions":5},{"name":"Spevigo","generic":"Spesolimab","trials":0,"payments":1,"publications":0,"mentions":1}]},"works_with":{"total":3,"shown":3,"withheld":0,"rows":[{"name":"Janssen Global Services, LLC","trials":0,"payments":4,"mentions":4},{"name":"Boehringer Ingelheim Pharmaceuticals, Inc.","trials":0,"payments":2,"mentions":2},{"name":"Hoth Therapeutics, Inc.","trials":1,"payments":0,"mentions":1}]}},"scholarship":{"works_count":69,"cited_by_count":517,"h_index":10,"i10_index":10,"pubmed_count":2,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT05639933","title":"Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"Hoth Therapeutics, Inc.","source_url":"https://clinicaltrials.gov/study/NCT05639933","trial_url":"https://www.findmykol.com/trial/NCT05639933"}],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2024,"last":2025},"rows_total":4,"shown":3,"withheld":1,"rows":[{"payer":"Janssen Global Services, LLC","program_year":2025,"amount_usd":2220,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1811948789"},{"payer":"Boehringer Ingelheim Pharmaceuticals, Inc.","program_year":2025,"amount_usd":93.89,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1811948789"},{"payer":"Janssen Global Services, LLC","program_year":2024,"amount_usd":555,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1811948789"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1811948789","source":"payments"},"prescribing":{"data_year":2024,"areas_total":8,"areas_shown":3,"areas":[{"area":"Dermatology","share_pct":29,"classes_total":7,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":14.7,"drugs":[{"name":"Triamcinolone Acetonide","share_pct":100}],"max_beneficiaries":96},{"class":"Interleukin-4 Receptor alpha Antagonist","setting":"prescribed","share_pct":8.4,"drugs":[{"name":"Dupixent Pen","share_pct":83.8},{"name":"Dupixent Syringe","share_pct":16.2}],"max_beneficiaries":null}]},{"area":"Anti-infectives","share_pct":28.2,"classes_total":5,"classes":[{"class":"Azole Antifungal","setting":"prescribed","share_pct":16,"drugs":[{"name":"Ketoconazole","share_pct":100}],"max_beneficiaries":84},{"class":"Lincosamide Antibacterial","setting":"prescribed","share_pct":4.5,"drugs":[{"name":"Clindamycin Phosphate","share_pct":100}],"max_beneficiaries":19}]},{"area":"Sensory organs","share_pct":18.3,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":18.3,"drugs":[{"name":"Clobetasol Propionate","share_pct":57.4},{"name":"Hydrocortisone","share_pct":42.6}],"max_beneficiaries":59}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":69.8,"facility_pct":30.2},"source":"medicare"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"publications":{"total":2,"shown":2,"withheld":0,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Evaluating Artificial Intelligence Models in Dermatology: Comparative Analysis.","year":2025,"journal":"JMIR dermatology","types":["Journal Article","Comparative Study"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41344880/","status":"verified"},{"title":"Dupilumab-associated psoriasis and psoriasiform dermatitis in patients with atopic dermatitis.","year":2022,"journal":"The Australasian journal of dermatology","types":["Letter"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/35460570/","status":"verified"}],"most_cited":{"total":69,"shown":5,"withheld":64,"rows":[{"title":"The banned sunscreen ingredients and their impact on human health: a systematic review","year":2020,"cited_by_count":118,"type":"review","source_url":"https://doi.org/10.1111/ijd.14824"},{"title":"Selection of Tumorigenic Melanoma Cells Using ALDH","year":2010,"cited_by_count":105,"type":"article","source_url":"https://doi.org/10.1038/jid.2010.237"},{"title":"Dupilumab-Induced Follicular Conjunctivitis","year":2018,"cited_by_count":44,"type":"article","source_url":"https://doi.org/10.1080/09273948.2018.1533567"},{"title":"Diffuse cutaneous mastocytosis: Case report and literature review","year":2018,"cited_by_count":32,"type":"article","source_url":"https://doi.org/10.1111/pde.13651"},{"title":"Cutaneous reactions with enfortumab vedotin: A case series and review of the literature","year":2021,"cited_by_count":31,"type":"article","source_url":"https://doi.org/10.1016/j.jdcr.2021.05.020"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Christina N. Kraus","coauthored_works":13},{"name":"Ashley N. Elsensohn","coauthored_works":8},{"name":"Anna‐Marie Hosking","coauthored_works":7,"profile_url":"https://www.findmykol.com/kol/anna-marie-hosking"}],"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/janellen-smith-md","status":"provisional"}]},"mentions":{"total":1,"shown":1,"rows":[{"url":"https://profiles.icts.uci.edu/janellen.smith","platform":"other","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":3,"shown":3,"rows":[{"value":"MD","source_url":"https://www.ucihealth.org/find-a-doctor/s/janellen-smith","status":"verified","collected_at":"2026-11-04"},{"value":"Board certification: American Board of Dermatology (Dermatology)","source_url":"https://www.ucihealth.org/find-a-doctor/s/janellen-smith","status":"verified","collected_at":"2026-11-04"},{"value":"Fellowship: Washington University, Molecular Biology and Dermatology","source_url":"https://www.ucihealth.org/find-a-doctor/s/janellen-smith","status":"verified","collected_at":"2026-11-04"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"UCI Health Chao Family Comprehensive Cancer Center (listed office, Orange, CA)","source_url":"https://www.ucihealth.org/find-a-doctor/s/janellen-smith","status":"provisional","collected_at":"2026-11-04"}]}},"similar":[{"name":"Susan O’Brien","slug":"susan-obrien","institution":"University of California, Irvine","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/susan-obrien","json_url":"https://www.findmykol.com/kol/susan-obrien/profile.json"},{"name":"Steven Potkin","slug":"steven-potkin","institution":"University of California, Irvine","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/steven-potkin","json_url":"https://www.findmykol.com/kol/steven-potkin/profile.json"},{"name":"Stefan Ciurea","slug":"stefan-ciurea","institution":"University of California, Irvine","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stefan-ciurea","json_url":"https://www.findmykol.com/kol/stefan-ciurea/profile.json"},{"name":"Farshid Dayyani","slug":"farshid-dayyani","institution":"University of California, Irvine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/farshid-dayyani","json_url":"https://www.findmykol.com/kol/farshid-dayyani/profile.json"},{"name":"Jedd Wolchok","slug":"jedd-wolchok","institution":"Weill Cornell Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jedd-wolchok","json_url":"https://www.findmykol.com/kol/jedd-wolchok/profile.json"},{"name":"Frank Hodi","slug":"frank-hodi","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/frank-hodi","json_url":"https://www.findmykol.com/kol/frank-hodi/profile.json"},{"name":"Keith Flaherty","slug":"keith-flaherty","institution":"Massachusetts General Hospital","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/keith-flaherty","json_url":"https://www.findmykol.com/kol/keith-flaherty/profile.json"},{"name":"Omid Hamid","slug":"omid-hamid","institution":"The Angeles Clinic and Research Institute","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/omid-hamid","json_url":"https://www.findmykol.com/kol/omid-hamid/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":1,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-04"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-04"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2024 to 2025","collected_at":"2026-11-04"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-04"}},"methodology_url":"https://www.findmykol.com/about#methodology"}